Bio-Techne Corporation (TECH)
NASDAQ
Closed
Aug 24, 2026
Day's Range
72.2752 wk Range
43.20Overview - TECH - Bio-Techne Corporation
Key Statistics
Valuation
Enterprise Value
11.31B
P/E (Trailing)
‪62.34‬
P/E (Forward)
‪31.21‬
PEG Ratio
‪0.45‬
Price / Sales (TTM)
‪9.27‬
Price / Book
‪5.42‬
EV / EBITDA
‪31.86‬
Profitability
Gross Margin
‪66.88%‬
Profit Margin
‪14.96%‬
Operating Margin
‪23.45%‬
Return on Assets
‪6.26%‬
Return on Equity
‪9.03%‬
Ownership
Shares Outstanding
156.51M
Float
155.44M
Short % of Shares Outstanding
‪6.80%‬
Held by Insiders
‪0.33%‬
Held by Institutions
‪114.94%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪68.87‬
200-Day Avg
‪60.35‬
Dividends
Payout Ratio
‪27.59%‬
Frequency
Quarterly
Analyst Consensus
14 analysts
Average price target
‪$ 70.73‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TECH - Bio-Techne Corporation
Peers - TECH - Bio-Techne Corporation
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
Profile Summary - TECH - Bio-Techne Corporation
About
Bio-Techne Corporation is a global life sciences company that develops, manufactures, and supplies specialized tools for research and clinical diagnostics. The company focuses on high-quality reagents, analytical instruments, and precision diagnostic products used across pharmaceutical, biotechnology, academic, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
